Wave Life Sciences

Wave Life Sciences

Yahoo Finance • 18 days ago

Wave Life Sciences Announces Initiation of Phase 2a Portion of INLIGHT™ Trial of WVE-007 (INHBE GalNAc-siRNA) for Obesity and Cardiometabolic Diseases

In Phase 1 portion of trial, WVE-007 improved body composition by inducing fat loss, including harmful visceral fat, while maintaining muscle; data continue to support once or twice-yearly dosing Phase 2a portion in individuals with highe... Full story

Yahoo Finance • 23 days ago

Is Sanofi (SNY) A Good Stock To Buy Now?

Is SNY a good stock to buy? We came across a bullish thesis on Sanofi on r/ValueInvesting by stefanliemawan. In this article, we will summarize the bulls' thesis on SNY. Sanofi's share was trading at $42.38 as of June 18th. SNY's trailing... Full story

Yahoo Finance • 29 days ago

Is Wave Life Sciences Ltd. (WVE) A Good Stock To Buy Now?

Is WVE a good stock to buy? We came across a bullish thesis on Wave Life Sciences Ltd. on Biotech Distilled's Substack. In this article, we will summarize the bulls' thesis on WVE. Wave Life Sciences Ltd.'s share was trading at $5.70 as of... Full story

Yahoo Finance • last month

Wave Life Sciences to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., June 01, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that m... Full story

Yahoo Finance • last month

This $5.5 Million Exit Raises Questions After Wave Life Sciences' Rough First Quarter

On May 15, 2026, Exome Asset Management reported selling out of Wave Life Sciences(NASDAQ:WVE), liquidating 421,488 shares in an estimated $5.49 million trade based on quarterly average pricing. What happened According to an SEC filing d... Full story

Yahoo Finance • 2 months ago

Wave Life Sciences to Present at 2026 RBC Capital Markets Global Healthcare Conference

CAMBRIDGE, Mass., May 13, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, today announced that Pa... Full story

Yahoo Finance • 2 months ago

Arrowhead (ARWR) Rated Buy on Metabolic Pipeline Potential

Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR) ranks among the most profitable biotech stocks to buy now. Following comments on Arrowhead Pharmaceuticals Inc. (NASDAQ:ARWR)’s obesity and metabolic illness initiatives, TD Cowen reiterated its... Full story

Yahoo Finance • 3 months ago

Wave Life Sciences Ltd. (WVE) Sees Strong Buy Rating From Analysts

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 10 Best Small-Cap Biotech Stocks According to Hedge Funds. The company’s stock registered a 22.39% growth from a year ago and a 53.04% percent decline year-to-date. Based on analyst consen... Full story

Yahoo Finance • 3 months ago

RBC Capital Maintains Outperform Rating on Wave Life Sciences (WVE)

Wave Life Sciences Ltd. (NASDAQ:WVE) is one of the 8 Healthcare Stocks Insiders Are Buying. On April 7, 2026, RBC Capital analyst Luca Issi lowered the price target on Wave Life Sciences Ltd. (NASDAQ:WVE) to $15 from $27 and maintained an... Full story

Yahoo Finance • 3 months ago

Is This Weight Loss Drug Stock a Buy on the Dip?

Key Points Wave Life Sciences' shares dropped after its weight loss candidate failed to impress in a phase 1 study. However, this product could actually be successful if it can confirm its recent phase 1 results. 10 stocks we like better... Full story

Yahoo Finance • 4 months ago

Stock Market Today, March 26: Wave Life Sciences Plunges After High Dose Obesity Drug Data Disappoints

Wave Life Sciences(NASDAQ:WVE), developer of RNA medicines for rare genetic diseases, closed Thursday at $6.20, down 49.59% for the session. The stock sank after disappointing higher-dose WVE-007 obesity data underperformed the lower dose.... Full story

Yahoo Finance • 4 months ago

Stock market today: Dow, S&P 500 sink, Nasdaq enters correction territory as oil spikes amid Iran war

US stocks sank on Thursday, with Big Tech and semiconductor stocks leading the sell-off. Conflicting messages from the US and Iran fueled mounting uncertainty over the Middle East conflict as oil hovered above $100. The tech-heavy Nasdaq... Full story

Yahoo Finance • 4 months ago

Stock market today: Dow, S&P 500, Nasdaq sink as Big Tech slides and oil spikes amid Iran war

US stocks accelerated losses on Thursday, with Big Tech and semiconductor stocks leading the market sell-off. Conflicting messages from the US and Iran fueled mounting uncertainty over the Middle East conflict as oil hovered above $100. T... Full story

Yahoo Finance • 4 months ago

Stock market today: Dow, S&P 500, Nasdaq sink as tech slides, Wall Street weighs prospects for Iran truce

US stocks accelerated losses on Thursday, with Big Tech and semiconductor stocks leading the market sell-off. Conflicting messages from the US and Iran fueled mounting uncertainty over the Middle East conflict as oil hovered above $100. T... Full story

Yahoo Finance • 4 months ago

Stock market today: Dow, S&P 500, Nasdaq sink as Wall Street weighs prospects for Iran truce

US stocks accelerated losses on Thursday as conflicting messages from the US and Iran fueled mounting uncertainty about the prospects for talks to end the Middle East conflict. The S&P 500 (^GSPC) fell 1.5%, while the tech-heavy Nasdaq Co... Full story

Yahoo Finance • 4 months ago

Top Midday Stories: Iran Reportedly Sends Formal Response to US Ceasefire Proposal; Corebridge, Equitable to Merge in $22 Billion All-Stock Deal

All three major US stock indexes were down in late-morning trading on Thursday as investors attempt PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium... Full story

Yahoo Finance • 4 months ago

Wave Plunges More Than 50% After Obesity Shot Falls Short

(Bloomberg) -- Wave Life Sciences Ltd. shares plunged their most on record after a single, higher-dose shot of its weight-loss drug failed to meet investor expectations for reducing visceral fat. The medicine, known as WVE-007, is intende... Full story

Yahoo Finance • 4 months ago

Here’s What Boosted Wave Life Sciences Ltd. (WVE) in Q4

Loomis Sayles, an investment management company, released its fourth-quarter 2025 investor letter for “Small Cap Growth Fund”. A copy of the letter is available to download here. The small caps' earnings are reaccelerating in 2025, as the... Full story

Yahoo Finance • 4 months ago

Wave Life Sciences Ltd. (WVE): A Bull Case Theory

We came across a bullish thesis on Wave Life Sciences Ltd. on X.com by @MoneyShow. In this article, we will summarize the bulls’ thesis on WVE. Wave Life Sciences Ltd.'s share was trading at $14.54 as of February 25th. Khosro/Shutterstock... Full story

Yahoo Finance • 5 months ago

Bank of America Predicts Up to 240% Jump for These 2 ‘Strong Buy’ Stocks

The stock market has been treading water so far this year, with the S&P 500 up roughly 1% while the Nasdaq has slipped 1.5%. Tech stocks have struggled to regain last year’s momentum as investors reassess the durability of AI-driven spendi... Full story